Skip to content
    UCL Technology Fund logo

    UCL Technology Fund

    London, United KingdomFounded 2016
    ucltf.co.ukLinkedIn
    Biotech & Life SciencesHealthcareAIData & Analytics

    UCL Technology Fund (UCLTF) is a venture capital fund dedicated to investing in intellectual property commercialisation opportunities arising from UCL's world-class research base. Managed by AlbionVC in collaboration with UCL Business, it focuses on physical sciences (AI, software, data analytics) and life sciences (gene therapy, medtech), funding spinouts from proof-of-concept through early-stage commercialisation.

    Deal activity increased 200% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (52% of deals). Average disclosed round size is $23.9M (across 21 rounds with reported amounts).

    Find people at UCL Technology Fund on Goldilocks AI

    Portfolio

    23

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    3

    Team

    Andrew Elder

    Andrew Elder

    Deputy Managing Partner at AlbionVC

    Christoph Ruedig

    Christoph Ruedig

    Partner at AlbionVC

    David Grimm

    David Grimm

    Partner

    Dr Peter Loudon

    Dr Peter Loudon

    Venture Partner

    Ed Lascelles

    Ed Lascelles

    Partner at AlbionVC

    Simon Goldman

    Simon Goldman

    Partner

    Stefanos Theoharis

    Stefanos Theoharis

    Venture Partner

    Takashi Takenoshita

    Takashi Takenoshita

    Venture Partner

    Richard Fagan

    Richard Fagan

    Director of BioPharm at UCL Business (UCLB)

    Leigh Brody

    Leigh Brody

    Investment Manager

    Sebastian Hunte

    Sebastian Hunte

    Investment Manager

    Tanel Ozdemir

    Tanel Ozdemir

    Investment Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    33 investments
    CompanyRoundAmountDate
    Gigaton logoGigatonSeries A$26MJun 2026
    Stanhope AI logoStanhope AISeries A$8MFeb 2026
    Stanhope AI logoStanhope AISeed$8MFeb 2026
    EpilepsyGTx logoEpilepsyGTxSeries A$33MJan 2025
    OOrioleSeries A$22MOct 2024
    Gaussion logoGaussionSeries A—Aug 2024
    EpilepsyGTx logoEpilepsyGTxSeed$10MJun 2024
    Oriole Networks logoOriole NetworksSeed—Mar 2024
    Phasecraft logoPhasecraftSeries A—Aug 2023
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries A$70MJul 2023
    IIntrinsic Semiconductor TechnologiesSeed—Mar 2023
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries A$70MJan 2023
    Carbon Re logoCarbon ReSeed$4.8MNov 2022
    Carbon Re logoCarbon ReSeries A$4.2MJan 2022
    Gaussion logoGaussionSeed—Jan 2022
    Quell Therapeutics logoQuell TherapeuticsSeries A$35MFeb 2021
    Nozzle logoNozzleUnknown$2.6MNov 2020
    Epsilogen Ltd logoEpsilogen LtdSeries A—Apr 2020
    Bramble Energy logoBramble EnergyUnknown$35MJan 2020
    Bramble logoBrambleSeries B—Jan 2020
    Echopoint Medical logoEchopoint MedicalSeed—Sep 2019
    Senya Tx logoSenya TxSeed—Jan 2019
    Third Space Learning logoThird Space LearningSeries A—Jan 2017
    Orchard Therapeutics logoOrchard TherapeuticsSeries A$33.4MMay 2016
    Orchard Therapeutics logoOrchard TherapeuticsSeries A$33.4MJan 2016
    Page 1 of 2

    Top Co-Investors

    AlbionVC11 shared
    Parkwalk Advisors7 shared
    BGF5 shared
    Clean Growth Fund5 shared
    F-Prime Capital5 shared
    British Patient Capital4 shared
    British Business Bank4 shared
    Auxxo Female Catalyst Fund3 shared
    Frontline Ventures3 shared
    Paladin Capital Group3 shared
    MMC Ventures3 shared
    Dorilton Ventures3 shared
    Planet A3 shared
    Cambridge Enterprise3 shared
    Qiming Venture Partners USA3 shared
    Sofinnova Partners3 shared
    Eight Roads3 shared
    Plural Platform3 shared
    XTX Markets2 shared
    Episode1 Ventures2 shared

    Last updated: 7 October 2026